| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.26 | 2e-06 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.21 | 0.0004 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |